Yes, receptors can be targeted for therapeutic interventions. Blocking receptor-pathogen interactions can prevent infections. Monoclonal antibodies and small-molecule inhibitors have been developed to block these interactions. For instance, antiviral drugs targeting the HIV-CD4 interaction have been successful in managing HIV infections.
